SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DTOX - CITA BIOMEDICAL, ULTRA RAPID OPIATE DETOXIFICATION

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cisco who wrote (26)2/17/1999 1:32:00 PM
From: Frank Buck  Read Replies (2) of 96
 
Could be that McCaffrey (White House drug policy director) is in favor of investigating the claims that C.I.T.A.'s Ultra Rapid Opiate Detoxification methodology (which I believe employs Naltrexone).... is a viable alternative to sentencing addicts to prison?

C.I.T.A.'s methodology of quickly cleansing the brain receptors from allowing heroin molecules to attach themselves to those receptors.... suggests that the euphoria associated with a drug relapse is removed. As such of course the follow up treatment (16 visits) to address the underlying addiction issues is also of paramount importance.

One older study suggests that C.I.T.A.'s methodology is not "cost versus benefit balanced". It also suggests that the risk of a fatality in 1 of 15,000 patients is too high. The possibility of a fatality exists as a consequence of the required anesthia procedure being administered to the patient. I wonder if a poll of opiate addicts think that a 1 in 15,000 chance at death is high considering that they are attempting to come clean??

Shouldn't that be compared with the odds for death at the hands of an overdose, unclean needles, contaminated drug-supply, dealing with criminals to obtain heroin, organ damage, etc...

Sounds to me like some are battling to maintain the status-quo methodology. Most new approaches at remediation have to openly address status-quo issues. Otherwise the status-quo proponents will launch sneak attacks at the flanks of the Ultra Rapid Opiate Detoxification technology. Amazingly the U.S. medical community needs mountains of data to look at... but when this data is available from the rest of the International Community the U.S. is slow to accept and adapt to it. Could this be a function of our insurance industry actuarial standards??

One thing is for sure.... that being if the proprietary nature of CITA's technology is endeared.... and accepted by the drug remediation sector.... the numbers you mention will assuredly quickly fall into place. Also your analysis doesn't provide for licensing agreeements established with International partners. I would like to hear some news from the likes of Australia and Britian and Canada.... in that regard. More U.S. Centers opening are certainly welcomed but I believe an International embrace is also very important.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext